Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present GeneSYS ID, Inc. (OTC: GNID).

Full DD Report for GNID

You must become a subscriber to view this report.

Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on GNID.

About GeneSYS ID, Inc. (OTC: GNID)

Logo for GeneSYS ID, Inc. (OTC: GNID)

GeneSYS ID designs, develops and manufactures innovative biometric products and systems that create more secure environments at home and at work improving both security and healthcare. Our innovative biometric products offer better security in the storage, dispensing and transportation of medication, and in medical devices providing accurate patient data to healthcare providers, payers as well as real time accurate data of clinical trials for pharmaceutical companies. Our award winning technology products have been adopted by world famous home security and healthcare brands and retailers. We operate through wholly owned subsidiaries MyTOUCH ID, bioHEALTHMED and GeneSYS RX. All of our companies products are secure, safe and accurate and are able to do a lot of things from opening doors to dispensing medication. We utilize unique human touch to identify homeowners and patients, allow access to control entry points and medical devices, and is something most people use every day in their cell phones. At GeneSYS ID, we believe in technology innovation that improves security in the home and at work as well as healthcare outcomes. By identifying the right patient, the right medication and sending accurate reports, from latch key kids to disease, from home security and heating and cooling access controls to secure accurate medical devices, we are the only company providing this solution through our wholly owned subsidiary s. We are changing the way we live, one touch at a time.




Current Management

  • Lorraine Yarde / CEO
    • Ms. Yarde is a Pioneer and Leader in the field of autonomous, embedded biometric products. Successfully launched first Nationwide Mass Market Distribution of Consumer Biometric Products Home Depot, Sears, Lowes, Costco, Sharper Proven ability to create strategic Product Development and Marketing relationships with brand Name OEMs to develop Fingerprint Products Master Lock, Black and Decker, Overhead Door Corporation, Honeywell Ms. Yarde is a successful serial entrepreneur and cofounded Rx Safes in with Mark Basile. Ms. Yarde has over years of experience in the biometric industry focusing on integrating fingerprint technology into every day consumer products. In , Ms. Yarde helped in the establishment of bioMETRX, a public company that simplified state of the art fingerprint technology and incorporated it into every day consumer products. Ms. Yarde was instrumental in establishing bioMETRX as a leader in the fledgling consumer biometric market and served as Chief Operating Officer and a member of the Board of Directors of bioMETRX. As a pioneer in the consumer biometric space, Ms. Yarde was responsible for providing strategic direction, driving revenue and securing and maintaining business relationships with major corporations.
  • William Koch / Chief Sales Officer, Chief Marketing Officer
  • Richard Iler / CFO
  • Faruk Okcetin / VP, Sales amp Bus. Dev.
    • For the last several years, Mr. Okcetin has been a Principle at Aspire Medical Services, a leading boutique medical distribution company that sells biologic, orthopedic, joint and spinal instrumentation and implants. He has worked directly with physicians, surgeons and hospital management, in supporting hospital and surgeon requirements to achieve the highest standard of care, and optimum patient results. Mr. Okcetin has been responsible for identifying and developing broad revenue channels for Aspire and intends to use this knowledge and experience to assist Rx Safes in marketing its products and technology to hospitals and healthcare facilities. Mr. Okcetin s previous business interests include RealEstate, Financial Sector, Restaurants, and a Tech Startup. He has also served in separate private industry board positions including an appointed position onto the Workforce Development Board in North Carolina and educational nonprofits. Mr. Okcetin also brings to bear an extensive background in capitalizing on social media, using technology, interactive voice recognition and artificial intelligence to connect existing business platforms to our every day lives.
  • Mark Basile / General Counsel
    • Mr. Basile, age . Mr. Basile, a successful attorney and serial entrepreneur, cofounded Rx Safes, Inc., in . Mr. Basile has over years of experience in the design, manufacture and marketing of fingerprint products both for the professional healthcare and home security markets. Mr. Basile founded and has taken public several other technologymedical companies focusing on biometric fingerprint design and integration into products and systems. Mr. Basile won the Smithsonian Award for Advances in Medical Technology for developing a fingerprint identification, access and retrieval system for electronic medical records. He also led one of those companies to a million dollar public market cap. During his tenure as CEO at bioMETRX, the company pioneered a line of fingerprint home security products, culminating in over million in sales orders in its first production year. Mr. Basile was also an original founding member of the EHealth Initiative the worlds largest trade organization located in Washington D.C., focusing on electronic healthcare initiatives with all of the largest healthcare companies and organizations. Mr. Basile was directly instrumental in raising more than million dollars for his prior companies and has coordinated corporate takeovers of some of his company s largest competitors.
  • William Koch /

Current Share Structure

  • Market Cap: $217,965 - 03/09/2018
  • Authorized: 500,000,000 - 11/15/2016
  • Issue and Outstanding: 17,437,232 - 11/15/2016
  • Float: 4,636,532 - 11/15/2016


Recent Filings from (OTC: GNID)

Correspondence from the SEC to the Filer
Filing Type: UPLOADFiling Source: edgar
Filing Date: December, 19 2017



Daily Technical Chart for (OTC: GNID)

Daily Technical Chart for (OTC: GNID)

Stay tuned for daily updates and more on (OTC: GNID)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: GNID)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

DD Report



Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in GNID is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of GNID and does not buy, sell, or trade any shares of GNID. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: